Atra stock forecast.

Atara Biotherapeutics, Inc. (Ticker: ATRA) closed the trading day on December 1, 2023, with a slight decline of 1.85%, ending the session at $0.65. The stock traded within a range of $0.57 to $0.65 on the same day, indicating a degree of volatility. ... the stock's technical outlook and negative profitability metrics pose considerable risks for ...

Atra stock forecast. Things To Know About Atra stock forecast.

ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock?The average Tempest Therapeutics stock price prediction forecasts a potential upside of 1,156.68% from the current TPST share price of $3.74. What is TPST's forecast return on equity (ROE) for 2023-2026? (NASDAQ: TPST) forecast ROE is N/A, which is …Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —. T Stock 12 Months Forecast. Based on 15 Wall Street analysts offering 12 month price targets for AT&T in the last 3 months. The average price target is $19.82 with a high forecast of $28.00 and a low forecast of $16.00. The average price target represents a 26.81% change from the last price of $15.63.Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...

Price vs Fair Value. View History. ATRA is trading within a range we consider fairly valued. Price. $0.70. Nov 29, 2023. Fair Value. $1.40. Nov 29, 2023.

The average Clene stock price prediction forecasts a potential upside of 1,558.99% from the current CLNN share price of $0.43. What is CLNN's forecast return on equity (ROE) for 2023-2026? (NASDAQ: CLNN) forecast ROE is N/A, which is considered weak.

Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why. Atara's (ATRA) shares fell after a phase II study evaluating its multiple sclerosis therapy did not meet its primary …The Trade Desk, Inc. (NASDAQ:TTD) issued its quarterly earnings data on Thursday, November, 9th. The technology company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.05. The technology company had revenue of $493.27 million for the quarter, compared to the consensus estimate of ...hace 7 días ... Atara Biotherapeutics Inc [NASDAQ: ATRA] stock went on an upward path that rose over 18.34% on Friday, amounting to a one-week price ...Oct 27, 2023 · Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions. Find real-time BLRX - BioLine RX Ltd stock quotes, company profile, news and forecasts from CNN Business.

Canoo Stock Forecast 11-30-2023. Forecast target price for 11-30-2023: $ 0.33. Negative dynamics for Canoo shares will prevail with possible volatility of 5.391%. Pessimistic target level: 0.32. Optimistic target level: 0.34.

Atara Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ATRA updated stock price target summary.

Find the latest Atara Biotherapeutics, Inc. ATRA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. …Atara Biotherapeutics stock forecast for 18.11.2023. Estimated Average Forecasted Atara Biotherapeutics Price: 1.92 Positive intraday dynamics of the instrument is expected with 2.384% volatility is expected. Pessimistic forecast: 1.89. Optimistic: 1.93. Atara Biotherapeutics stock forecast for 19.11.2023.$0.65. DRRX 5.13%. Outlook Therapeutics Inc. $0.47. OTLK 1.50%. Gamida Cell Ltd. $0.33. GMDA 6.45%. Atara Biotherapeutics Inc. $0.65. ATRA 1.85%. Aclaris ...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Amazon Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

16 sept 2020 ... See if the stock goes on to build a promising consolidation that could kick off a new price move. Atara Biotherapeutics (ATRA).12 brokers have issued 1 year price objectives for TC Energy's stock. Their TRP share price targets range from C$47.00 to C$64.00. On average, they expect the company's share price to reach C$55.06 in the next twelve months. This suggests a possible upside of 9.2% from the stock's current price. View analysts price targets for TRP or …NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.Stock Price Forecast The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ...Goldman Sachs Sticks to Its Sell Rating for Atara Biotherapeutics (ATRA) November 9, 2023TipRanks. Atara Biotherapeutics downgraded to In Line from Outperform at Evercore ISI November 9 ...Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Nov 16, 2023 · It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecasts HRTX Stock 12 Months Forecast. $9.00. (1402.00% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Heron Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 1402.00% change from the last price of $0.60.The current average ATRA price target, as estimated by these analysts, is $3.00. The predictions for the future ATRA stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for ATRA.Nov 24, 2023 · The Atara Biotherapeutics stock price gained 13.93% on the last trading day (Friday, 24th Nov 2023), rising from $0.572 to $0.652. During the last trading day the stock fluctuated 29.65% from a day low at $0.552 to a day high of $0.716. The price has risen in 8 of the last 10 days and is up by 171.54% over the past 2 weeks. Find real-time MO - Altria Group Inc stock quotes, company profile, news and forecasts from CNN Business.The latest Atara Biotherapeutics stock prices, stock quotes, news, and ATRA history to help you invest and trade smarter. ... The 18 analysts offering price forecasts for Atara Biotherapeutics ...Find the latest dividend history for Atara Biotherapeutics, Inc. Common Stock (ATRA) at Nasdaq.com.Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —.

Dec 1, 2023 · Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.

Nov 27, 2023 · Price Prediction forecast forAtara Biotherapeutics to November 28, and an in-depth analysis for the week of 26 November to 2 December. Monthly forecasts ATRA for 2023 with target levels, support & resistance insights to make informed investment decisions.

3 Wall Street research analysts have issued twelve-month target prices for Trulieve Cannabis' stock. Their TCNNF share price targets range from $6.00 to $132.00. On average, they anticipate the company's stock price to reach $42.92 in the next year. This suggests a possible upside of 693.3% from the stock's current price.Stock Price Forecast The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ... Nov 27, 2023 · Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (2.683 $). Dec 1, 2023 · Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million. Jun 30, 2023 · ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? Dec 1, 2023 · Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million. Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 89.50, with a high estimate of 104.00 and a low estimate of 68.00. The median ...The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility ...NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...The average Precigen stock price prediction forecasts a potential upside of 792.86% from the current PGEN share price of $1.12. What is PGEN's forecast return on equity (ROE) for 2023-2026? (NASDAQ: PGEN) forecast ROE is N/A, which is considered weak.According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00.Instagram:https://instagram. draped bust dollaramerican general life insurance ratingssandp 500 financialscurrent rate of i bonds Nov 24, 2023 · THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare Conference does roto rooter offer financingledger nano s vs x Sep 19, 2023 · Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58. Their NVDA share price targets range from $195.00 to $780.00. On average, they predict the company's stock price to reach $588.38 in the next year. This suggests a possible upside of 25.8% from the stock's current price. View analysts price targets for NVDA or view top-rated stocks among Wall Street analysts. adobe stocjk Amazon Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.Nov 15, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.